These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Estrogen and progestogen therapy in postmenopausal women. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850 [No Abstract] [Full Text] [Related]
44. Hormone replacement therapy and the menopause. Australian Menopause Society. MacLennan AH Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437 [No Abstract] [Full Text] [Related]
45. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s]. Magnusson C; Reeves G Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095 [No Abstract] [Full Text] [Related]
46. The use of oestrogens and progestin and the risk of breast cancer in post-menopausal women. G.A. Colditz et al. N. Engl. J. Med. 1995; 332: 1589-93. Kauppila A Pharmacol Res; 1995 Dec; 32(6):327. PubMed ID: 8736481 [No Abstract] [Full Text] [Related]
47. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. van Leeuwen FE Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500 [TBL] [Abstract][Full Text] [Related]
48. Increased coronary events, HERS, and HRT: any connection? Rebar RW; Archer D Arch Intern Med; 2001 May; 161(10):1350-1. PubMed ID: 11371266 [No Abstract] [Full Text] [Related]
49. [Evidence based basis of decision making for or against a postmenopausal hormone treatment]. Rásky E Wien Klin Wochenschr; 2004 Jul; 116(14):461-4; discussion 504. PubMed ID: 15379140 [No Abstract] [Full Text] [Related]
50. The sound of an International anti-HRT herald. Genazzani AR; Gambacciani M Maturitas; 2003 Oct; 46(2):105-6. PubMed ID: 14559378 [No Abstract] [Full Text] [Related]
51. Weighing the risks and benefits of hormone therapy. Toth S; Blanchard E; Herman L; Larson L; Léger MM; McNellis R; Quigley T; Van Dyke E JAAPA; 2003 Jun; 16(6):45-7. PubMed ID: 14968505 [No Abstract] [Full Text] [Related]
52. Postmenopausal estrogens--opposed, unopposed, or none of the above. Willett WC; Colditz G; Stampfer M JAMA; 2000 Jan; 283(4):534-5. PubMed ID: 10659883 [No Abstract] [Full Text] [Related]
53. Risks and benefits of hormone therapy: has medical dogma now been overturned? Shapiro S; de Villiers TJ; Pines A; Sturdee DW; Baber RJ; Panay N; Stevenson JC; Mueck AO; Burger HG Climacteric; 2014 Jun; 17(3):215-22. PubMed ID: 24654673 [TBL] [Abstract][Full Text] [Related]
54. Risk of breast cancer with HRT depends on therapy type and duration. Saul H; Gursul D; Cassidy S; Vinogradova Y BMJ; 2022 Mar; 376():o485. PubMed ID: 35260385 [TBL] [Abstract][Full Text] [Related]
56. [Estrogens and progestins in hormone replacement therapy in menopause]. La Vecchia C Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854 [TBL] [Abstract][Full Text] [Related]
57. Hormone replacement therapy for women with a past history of breast cancer. Stoll BA Clin Oncol (R Coll Radiol); 1990 Nov; 2(6):309-12. PubMed ID: 2278887 [No Abstract] [Full Text] [Related]
58. Hormone replacement therapy and breast cancer risk. Campagnoli C; Biglia N; Sismondi P JAMA; 1996 Apr; 275(15):1159-60. PubMed ID: 8609680 [No Abstract] [Full Text] [Related]